These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38994031)

  • 1. CBX4 suppresses CD8
    Wang J; Jia W; Zhou X; Ma Z; Liu J; Lan P
    Theranostics; 2024; 14(10):3793-3809. PubMed ID: 38994031
    [No Abstract]   [Full Text] [Related]  

  • 2. Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α-Glycolysis Pathway.
    Lv Q; Su T; Liu W; Wang L; Hu J; Cheng Y; Ning C; Shan W; Luo X; Chen X
    Cancer Immunol Res; 2024 Aug; 12(8):1058-1073. PubMed ID: 38752667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CBX4 promotes antitumor immunity by suppressing Pdcd1 expression in T cells.
    Ren L; Li Z; Zhou Y; Zhang J; Zhao Z; Wu Z; Zhao Y; Ju Y; Pang X; Sun X; Wang W; Zhang Y
    Mol Oncol; 2023 Dec; 17(12):2694-2708. PubMed ID: 37691307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation and antitumor immunity of CD8
    Liu Y; Wang F; Peng D; Zhang D; Liu L; Wei J; Yuan J; Zhao L; Jiang H; Zhang T; Li Y; Zhao C; He S; Wu J; Yan Y; Zhang P; Guo C; Zhang J; Li X; Gao H; Li K
    Sci Transl Med; 2024 Aug; 16(762):eadk7399. PubMed ID: 39196962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progression.
    Zhao H; Jiang R; Feng Z; Wang X; Zhang C
    J Transl Med; 2023 Nov; 21(1):833. PubMed ID: 37980488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-κB-inducing kinase maintains T cell metabolic fitness in antitumor immunity.
    Gu M; Zhou X; Sohn JH; Zhu L; Jie Z; Yang JY; Zheng X; Xie X; Yang J; Shi Y; Brightbill HD; Kim JB; Wang J; Cheng X; Sun SC
    Nat Immunol; 2021 Feb; 22(2):193-204. PubMed ID: 33398181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting Edge: Polycomb Repressive Complex 1 Subunit Cbx4 Positively Regulates Effector Responses in CD8 T Cells.
    Melo GA; Xu T; Calôba C; Schutte A; Passos TO; Neto MAN; Brum G; Oliveira-Vieira B; Higa L; Monteiro FLL; Berbert L; Gonçalves ANA; Tanuri A; Viola JPB; Werneck MBF; Nakaya HI; Pipkin ME; Martinez GJ; Pereira RM
    J Immunol; 2023 Sep; 211(5):721-726. PubMed ID: 37486206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cytokine Meteorin-like inhibits anti-tumor CD8
    Jackson CM; Pant A; Dinalankara W; Choi J; Jain A; Nitta R; Yazigi E; Saleh L; Zhao L; Nirschl TR; Kochel CM; Hwa-Lin Bergsneider B; Routkevitch D; Patel K; Cho KB; Tzeng S; Neshat SY; Kim YH; Smith BJ; Ramello MC; Sotillo E; Wang X; Green JJ; Bettegowda C; Li G; Brem H; Mackall CL; Pardoll DM; Drake CG; Marchionni L; Lim M
    Immunity; 2024 Aug; 57(8):1864-1877.e9. PubMed ID: 39111315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 Activation-Induced Fatty Acid Oxidation in CD8
    Zhang C; Yue C; Herrmann A; Song J; Egelston C; Wang T; Zhang Z; Li W; Lee H; Aftabizadeh M; Li YJ; Lee PP; Forman S; Somlo G; Chu P; Kruper L; Mortimer J; Hoon DSB; Huang W; Priceman S; Yu H
    Cell Metab; 2020 Jan; 31(1):148-161.e5. PubMed ID: 31761565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation.
    Pollizzi KN; Patel CH; Sun IH; Oh MH; Waickman AT; Wen J; Delgoffe GM; Powell JD
    J Clin Invest; 2015 May; 125(5):2090-108. PubMed ID: 25893604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cell cycle regulator p16 promotes tumor infiltrated CD8
    Zhang X; Wang J; Tang K; Yang Y; Liu X; Yuan S; Guo F; Zhang L; Ma K
    Cell Death Dis; 2024 May; 15(5):339. PubMed ID: 38750022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8
    Wu Q; Liu Z; Gao Z; Luo Y; Li F; Yang C; Wang T; Meng X; Chen H; Li J; Kong Y; Dong C; Sun S; Chen C
    Theranostics; 2023; 13(4):1381-1400. PubMed ID: 36923542
    [No Abstract]   [Full Text] [Related]  

  • 13. Toll-Like Receptor 7 Activation Enhances CD8+ T Cell Effector Functions by Promoting Cellular Glycolysis.
    Li Q; Yan Y; Liu J; Huang X; Zhang X; Kirschning C; Xu HC; Lang PA; Dittmer U; Zhang E; Lu M
    Front Immunol; 2019; 10():2191. PubMed ID: 31572396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function.
    Sukumar M; Liu J; Ji Y; Subramanian M; Crompton JG; Yu Z; Roychoudhuri R; Palmer DC; Muranski P; Karoly ED; Mohney RP; Klebanoff CA; Lal A; Finkel T; Restifo NP; Gattinoni L
    J Clin Invest; 2013 Oct; 123(10):4479-88. PubMed ID: 24091329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8
    Ping Y; Shan J; Qin H; Li F; Qu J; Guo R; Han D; Jing W; Liu Y; Liu J; Liu Z; Li J; Yue D; Wang F; Wang L; Zhang B; Huang B; Zhang Y
    Immunity; 2024 Sep; 57(9):2122-2139.e9. PubMed ID: 39208806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation.
    Beckermann KE; Hongo R; Ye X; Young K; Carbonell K; Healey DCC; Siska PJ; Barone S; Roe CE; Smith CC; Vincent BG; Mason FM; Irish JM; Rathmell WK; Rathmell JC
    JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32814710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fructose-1, 6-Bisphosphate Aldolase B Suppresses Glycolysis and Tumor Progression of Gastric Cancer.
    Wu L; Dong J; Fei D; Le T; Xiao L; Liu J; Yu Z
    Dig Dis Sci; 2024 Sep; 69(9):3290-3304. PubMed ID: 39068380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromobox 4 facilitates tumorigenesis of lung adenocarcinoma through the Wnt/β-catenin pathway.
    Wang Z; Fang Z; Chen G; Liu B; Xu J; Li F; Li F; Liu H; Zhang H; Sun Y; Tian G; Chen H; Xu G; Zhang L; Hu L; Ji H
    Neoplasia; 2021 Feb; 23(2):222-233. PubMed ID: 33387960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting ONECUT3 blocks glycolytic metabolism and potentiates anti-PD-1 therapy in pancreatic cancer.
    Chen PC; Ning Y; Li H; Su JG; Shen JB; Feng QC; Jiang SH; Shi PD; Guo RS
    Cell Oncol (Dordr); 2024 Feb; 47(1):81-96. PubMed ID: 37606818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fructose-1,6-Bisphosphate Aldolase B Depletion Promotes Hepatocellular Carcinogenesis Through Activating Insulin Receptor Signaling and Lipogenesis.
    Liu G; Wang N; Zhang C; Li M; He X; Yin C; Tu Q; Shen X; Zhang L; Lv J; Wang Y; Jiang H; Chen S; Li N; Tao Y; Yin H
    Hepatology; 2021 Dec; 74(6):3037-3055. PubMed ID: 34292642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.